Research Paper Volume 12, Issue 9 pp 8151—8166

Salidroside inhibits platelet function and thrombus formation through AKT/GSK3β signaling pathway

Figure 4. Effect of salidroside on mouse platelet function. Washed mouse platelets were treated with vehicle or 20 μM salidroside followed by measuring platelet aggregation and ATP release in response to thrombin (0.02 U/ml) (A) or CRP (0.05 μg/ml) (B) as well as thrombin-mediated clot retraction (C). For panel A and B, data were presented as mean ± SE (n = 3-4) and analyzed by unpaired student t-test. *P < 0.05. For panel C, data were shown as mean (n = 3-4) and analyzed by two-way ANOVA. Compared with 0, *P < 0.05; **P < 0.01.